These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 4145866)

  • 21. A clinical study with propericiazine in chronic psychotic patients.
    Deutsch M; Ananth JV; Ban TA
    Curr Ther Res Clin Exp; 1971 Jun; 13(6):353-8. PubMed ID: 4397391
    [No Abstract]   [Full Text] [Related]  

  • 22. Evaluation of butaperazine in chronic schizophrenia.
    Clark ML; Ray TS; Huber WK; Willis D; Ramsey HR
    Clin Pharmacol Ther; 1968; 9(6):757-64. PubMed ID: 4387043
    [No Abstract]   [Full Text] [Related]  

  • 23. Clinical evaluation of butaperazine.
    Feldman PE
    Psychosomatics; 1967; 8(1):26-8. PubMed ID: 4382889
    [No Abstract]   [Full Text] [Related]  

  • 24. Liquid butaperazine in the treatment of chronic psychosis in a mental health clinic.
    Clare G; Simeon J; Fink M
    Curr Ther Res Clin Exp; 1969 Feb; 11(2):57-63. PubMed ID: 4388407
    [No Abstract]   [Full Text] [Related]  

  • 25. Uncontrolled study with pipothiazine palmitate.
    Jain RC; Ananth JV; Klingner A; Ban TA; Lehmann HE
    Int J Clin Pharmacol; 1973 Feb; 7(1):32-6. PubMed ID: 4699381
    [No Abstract]   [Full Text] [Related]  

  • 26. Butaperazine and prochlorperazine; a comparative trial of two phenothiazines.
    Bordeleau JM; Rajotte P; Tétreault L
    Chemotherapia (Basel); 1964-1965; 9(4):248-58. PubMed ID: 4378567
    [No Abstract]   [Full Text] [Related]  

  • 27. Prediction of response to phenothiazines in schizophrenia. A crossvalidation study.
    Goldberg SC; Frosch WA; Drossman AK; Schooler NR; Johnson GF
    Arch Gen Psychiatry; 1972 Apr; 26(4):367-73. PubMed ID: 4552130
    [No Abstract]   [Full Text] [Related]  

  • 28. A double-blind comparison of the therapeutic efficacy of mesoridazine versus chlorpromazine.
    Freeman H; Oktem MR; Oktem N
    Curr Ther Res Clin Exp; 1969 May; 11(5):263-70. PubMed ID: 4977397
    [No Abstract]   [Full Text] [Related]  

  • 29. Comparison of dosage ranges of carphenazine and trifluoperazine in elderly chronic schizophrenics.
    Bora G
    Dis Nerv Syst; 1968 Oct; 29(10):695-7. PubMed ID: 4887393
    [No Abstract]   [Full Text] [Related]  

  • 30. Reappraisal of nurse's role in the treatment of schizophrenia.
    Kelleher MJ
    Int J Nurs Stud; 1974 Dec; 11(4):197-202. PubMed ID: 4497842
    [No Abstract]   [Full Text] [Related]  

  • 31. [Clinical experiences with thiothixene (navane) in chronic schizophrenia].
    Gann G
    Wien Med Wochenschr; 1968 Jan; 118(1):10-3. PubMed ID: 5668801
    [No Abstract]   [Full Text] [Related]  

  • 32. Pharmacokinetics of red blood cell phenothiazine and clinical effects. Acute dystonic reactions.
    Garver DL; Davis JM; Dekirmenjian H; Jones FD; Casper R; Haraszti J
    Arch Gen Psychiatry; 1976 Jul; 33(7):862-6. PubMed ID: 8025
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Quide vs. Mellaril in chronic schizophrenic patients.
    Gallant DM; Bishop MP
    Curr Ther Res Clin Exp; 1972 Jan; 14(1):10-6. PubMed ID: 4621558
    [No Abstract]   [Full Text] [Related]  

  • 34. Lack of effect of a gluten-free diet on neuroleptic blood levels in schizophrenic patients.
    Osborne M; Crayton JW; Javaid J; Davis JM
    Biol Psychiatry; 1982 May; 17(5):627-9. PubMed ID: 6124283
    [No Abstract]   [Full Text] [Related]  

  • 35. Problems in the evaluation of the optimal dose of a phenothiazine (butaperazine).
    Simpson GM; Amin M; Kunz-Bartholini E; Watts TP; Laska E
    Dis Nerv Syst; 1968 Jul; 29(7):478-84. PubMed ID: 4386374
    [No Abstract]   [Full Text] [Related]  

  • 36. Indications for high dose chlorpromazine therapy in chronic schizophrenia.
    Prien RF; Levine J; Cole JO
    Dis Nerv Syst; 1970 Nov; 31(11):739-45. PubMed ID: 4923151
    [No Abstract]   [Full Text] [Related]  

  • 37. Schizophrenics: the efficacy of phenothiazines.
    McNamee HB
    Am J Psychiatry; 1971 Nov; 128(5):657. PubMed ID: 5114388
    [No Abstract]   [Full Text] [Related]  

  • 38. Pipotiazine palmitate: an evaluation of a new long acting intramuscular antipsychotic agent in severely ill schizophrenic patients.
    Gallant DM; Mielke D; Bishop G; Oelsner T; Guerrero-Figueroa R
    Dis Nerv Syst; 1975 Apr; 36(4):193-6. PubMed ID: 1090427
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A versatile new sustained-action neuroleptic: pipotiazine palmitate in psychiatric practice.
    Johnston RE; Niesink F
    J Int Med Res; 1979; 7(3):187-93. PubMed ID: 37133
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Comparative study of butaperazine and prochlorperazine for schizophrenia in acute phase].
    Albert JM; Rajotte P; Rajotte E; Tétreault L
    Union Med Can; 1970 Jul; 99(7):1282-5. PubMed ID: 4396306
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.